NCT06098339 is a NA clinical trial of Lens A (fanfilcon A) in Myopia, sponsored by CooperVision, Inc..

Who is sponsoring NCT06098339?

NCT06098339 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT06098339?

Interventions in NCT06098339: Lens A (fanfilcon A), Lens B (lotrafilcon B).

What condition does NCT06098339 study?

NCT06098339 studies Myopia, Hyperopia.

Is NCT06098339 still recruiting?

NCT06098339 is currently completed. Last updated 28 August 2024.

Are results published for NCT06098339?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-08-28 · How we verify

NCT06098339

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers

Completed NA Results posted Last updated 28 August 2024

What this trial tests

NA trial testing Lens A (fanfilcon A) in Myopia in 53 participants. Completed in 4 April 2024.

Timeline

13 November 2023

Primary endpoint
4 April 2024

4 April 2024

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	53
Start date	13 November 2023
Primary completion	4 April 2024
Estimated completion	4 April 2024
Sites	3 locations across Canada, United States

Drugs / interventions tested

Lens A (fanfilcon A)
Lens B (lotrafilcon B)

Conditions studied

Myopia — all drugs for Myopia →
Hyperopia — all drugs for Hyperopia →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 39, any sex, with Myopia or Hyperopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Lens Handling on Removal Primary · Day 27

Participants measured subjective lens handling at removal on a 0-100 integer scale, where 0=worst and 100=best. Results for each lens were collected in the at-home diary on Day 27.

Group	Value	95% CI
Lens A	84	± 21
Lens B	89	± 17

Adverse events — posted to ClinicalTrials.gov

Time frame: The duration of the clinical trial, approximately 2-3 months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Lens A

Serious: 0/50 (0%)

Deaths: 0/50

Lens B

Serious: 0/50 (0%)

Deaths: 0/50

Other adverse events (6 terms — click to expand)

Reaction	System	Lens A	Lens B
Ocular discomfort,	Eye disorders	—	—
Viral conjunctivitis	Eye disorders	—	—
Asymptomatic corneal infiltrate event	Eye disorders	—	—
Lower lid small chalazion	Eye disorders	—	—
Nasal upper lid papilloma	Eye disorders	—	—
Upper respiratory tract infection	Respiratory, thoracic and mediastinal disorders	—	—

Data from ClinicalTrials.gov NCT06098339 adverse events section.

Sponsor's own description

The purpose of this study was to compare the clinical performance of two different reusable lenses in habitual spherical soft lens wearers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lens A (fanfilcon A)

Trials testing the same drug.

NCT05097144 — Performance of Toric Silicone Hydrogel Contact Lenses · NA · completed

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06098339 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 28 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06098339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing